DK2521547T3 - Fremgangsmåder og sammensætninger til påføring af moxifloxacin til ørene - Google Patents
Fremgangsmåder og sammensætninger til påføring af moxifloxacin til øreneInfo
- Publication number
- DK2521547T3 DK2521547T3 DK11732210.7T DK11732210T DK2521547T3 DK 2521547 T3 DK2521547 T3 DK 2521547T3 DK 11732210 T DK11732210 T DK 11732210T DK 2521547 T3 DK2521547 T3 DK 2521547T3
- Authority
- DK
- Denmark
- Prior art keywords
- ears
- compositions
- methods
- moxifloxacin
- applying
- Prior art date
Links
- 210000005069 ears Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 title 1
- 229960003702 moxifloxacin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29301910P | 2010-01-07 | 2010-01-07 | |
| PCT/US2011/020531 WO2011085209A2 (en) | 2010-01-07 | 2011-01-07 | Methods and compositions for applying moxifloxacin to the ear |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2521547T3 true DK2521547T3 (da) | 2017-11-20 |
Family
ID=44306169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11732210.7T DK2521547T3 (da) | 2010-01-07 | 2011-01-07 | Fremgangsmåder og sammensætninger til påføring af moxifloxacin til ørene |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20120289541A1 (da) |
| EP (2) | EP2521547B1 (da) |
| JP (3) | JP2013516485A (da) |
| KR (2) | KR101835895B1 (da) |
| CN (2) | CN106309356A (da) |
| AU (1) | AU2011204275B2 (da) |
| BR (1) | BR112012016809A2 (da) |
| CA (1) | CA2786525A1 (da) |
| CL (1) | CL2012001835A1 (da) |
| CY (1) | CY1119493T1 (da) |
| DK (1) | DK2521547T3 (da) |
| ES (1) | ES2644826T3 (da) |
| HR (1) | HRP20171592T1 (da) |
| HU (1) | HUE035586T2 (da) |
| LT (1) | LT2521547T (da) |
| MX (1) | MX337419B (da) |
| NO (1) | NO2521547T3 (da) |
| PL (1) | PL2521547T3 (da) |
| PT (1) | PT2521547T (da) |
| RU (2) | RU2016101214A (da) |
| SI (1) | SI2521547T1 (da) |
| WO (1) | WO2011085209A2 (da) |
| ZA (1) | ZA201205965B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| KR102269511B1 (ko) * | 2012-06-28 | 2021-06-24 | 더 어드미니스트레이터 오브 더 튜레인 에듀케이셔널 펀드 | 선택적 중합성 조성물 및 생체 내에서 사용 방법 |
| CN103869033B (zh) * | 2012-12-14 | 2016-10-05 | 南京长澳医药科技有限公司 | 一种液相色谱法分离测定盐酸莫西沙星及其杂质的方法 |
| JP6255134B1 (ja) * | 2016-11-02 | 2017-12-27 | ヴェローチェ・バイオファーマ・エルエルシー | 耳炎の治療のための組成物および方法 |
| EP3720465A1 (en) | 2017-12-08 | 2020-10-14 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
| CN108593696B (zh) * | 2018-04-26 | 2020-11-03 | 南京明捷生物医药检测有限公司 | 一种利用定量核磁测定多肽中三氟乙酸残留的方法 |
| CN117045593A (zh) * | 2023-09-19 | 2023-11-14 | 上海市第六人民医院 | 一种用于慢性中耳炎治疗的抗菌温敏水凝胶及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6201072B1 (en) | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| AR020661A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| JP3450805B2 (ja) * | 2000-08-08 | 2003-09-29 | わかもと製薬株式会社 | 水性医薬組成物 |
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| MX2007005980A (es) * | 2004-12-10 | 2007-07-10 | Alcon Inc | Composiciones para el tratamiento de infecciones oticas. |
| US8822410B2 (en) * | 2008-05-19 | 2014-09-02 | Children's Medical Center Corporation | Tympanic membrane permeating ear drops and uses thereof |
-
2011
- 2011-01-07 MX MX2012007928A patent/MX337419B/es active IP Right Grant
- 2011-01-07 PL PL11732210T patent/PL2521547T3/pl unknown
- 2011-01-07 US US13/520,519 patent/US20120289541A1/en not_active Abandoned
- 2011-01-07 CN CN201610909298.7A patent/CN106309356A/zh not_active Withdrawn
- 2011-01-07 EP EP11732210.7A patent/EP2521547B1/en active Active
- 2011-01-07 ES ES11732210.7T patent/ES2644826T3/es active Active
- 2011-01-07 AU AU2011204275A patent/AU2011204275B2/en not_active Ceased
- 2011-01-07 BR BR112012016809A patent/BR112012016809A2/pt not_active Application Discontinuation
- 2011-01-07 KR KR1020127020775A patent/KR101835895B1/ko active IP Right Grant
- 2011-01-07 KR KR1020187005804A patent/KR20180027611A/ko not_active Application Discontinuation
- 2011-01-07 RU RU2016101214A patent/RU2016101214A/ru not_active Application Discontinuation
- 2011-01-07 SI SI201131326T patent/SI2521547T1/en unknown
- 2011-01-07 EP EP17186323.6A patent/EP3305280A1/en not_active Withdrawn
- 2011-01-07 HU HUE11732210A patent/HUE035586T2/en unknown
- 2011-01-07 CN CN2011800127647A patent/CN102791270A/zh active Pending
- 2011-01-07 NO NO11732210A patent/NO2521547T3/no unknown
- 2011-01-07 CA CA2786525A patent/CA2786525A1/en not_active Abandoned
- 2011-01-07 PT PT117322107T patent/PT2521547T/pt unknown
- 2011-01-07 JP JP2012548156A patent/JP2013516485A/ja active Pending
- 2011-01-07 RU RU2012133568/15A patent/RU2576029C2/ru not_active IP Right Cessation
- 2011-01-07 LT LTEP11732210.7T patent/LT2521547T/lt unknown
- 2011-01-07 DK DK11732210.7T patent/DK2521547T3/da active
- 2011-01-07 WO PCT/US2011/020531 patent/WO2011085209A2/en active Application Filing
-
2012
- 2012-07-06 CL CL2012001835A patent/CL2012001835A1/es unknown
- 2012-08-07 ZA ZA2012/05965A patent/ZA201205965B/en unknown
-
2016
- 2016-02-05 JP JP2016020395A patent/JP6267246B2/ja not_active Expired - Fee Related
-
2017
- 2017-10-18 HR HRP20171592TT patent/HRP20171592T1/hr unknown
- 2017-10-18 CY CY20171101086T patent/CY1119493T1/el unknown
- 2017-12-21 JP JP2017245040A patent/JP2018076352A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2857401T3 (da) | Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme | |
| DK2929031T5 (da) | Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf | |
| DK3421051T3 (da) | Fremgangsmåder til glycokonjugering og sammensætninger | |
| DK2884999T3 (da) | Fremgangsmåde og sammensætninger til cellulær immunterapi | |
| DK2655370T3 (da) | Sammensætninger og fremgangsmåder til modulering af FXR-receptorer | |
| DK2739293T3 (da) | Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus | |
| DK2914627T3 (da) | Anti-cd40-antistoffer og fremgangsmåder til anvendelse | |
| DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
| DK3202460T3 (da) | Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme | |
| AP3965A (en) | Anthelminitic compounds and compositions and method of using thereof | |
| DK2877599T3 (da) | Fremgangsmåder og sammensætninger til bestemmelse af resistens overfor androgenreceptorterapi | |
| DK2675827T3 (da) | Hidtil ukendte modulatorer og fremgangsmåder til anvendelse | |
| DK2768321T3 (da) | Fremgangsmåder og sammensætninger til induktion af mæthed | |
| BR112012015988A2 (pt) | método | |
| DK2928921T3 (da) | Sammensætninger og fremgangsmåder til antistoffer målrettet epo | |
| DK2622532T3 (da) | Fremgangsmåde til kollaborativ beregning | |
| BR112014010450A2 (pt) | composição e método | |
| DK2922955T3 (da) | Sammensætninger og fremgangsmåder til modulering af FGFR3-ekspression | |
| DK3095817T3 (da) | Mikrogelsammensætninger | |
| DK2533761T3 (da) | Fremgangsmåder og sammensætninger til fremstilling af aerosoler | |
| DK2793895T3 (da) | Fremgangsmåder og sammensætninger til reducering af kropsfedt og adipocytter | |
| DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
| DK2830654T3 (da) | Metoder og sammensætninger til behandling af inflammation | |
| DK2582871T3 (da) | Doseringsapparat og fremgangsmåde til dosering af en sammensætning | |
| DK2521547T3 (da) | Fremgangsmåder og sammensætninger til påføring af moxifloxacin til ørene |